CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML

CONCLUSION: CPT1B is a potential prognostic factor and a therapeutic target for AML treatment.PMID:36938722 | DOI:10.3233/CBM-210043

Source: Cancer Biomarkers : Section A of Disease Markers - March 20, 2023 Category: Cancer & Oncology Authors: Qing Ling Shihui Mao Jiajia Pan Wenwen Wei Yu Qian Fenglin Li Shujuan Huang Wenle Ye Xiangjie Lin Jiansong Huang Jinghan Wang Jie Jin Source Type: research